Treatment of acute ischemic stroke: Part II: neuroprotection and medical management.
Broderick
Joseph P
JP
Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA. joseph.broderick@ uc.edu
Hacke
Werner
W
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001929:Brain Edema / Q000209:etiology / Q000628:therapy; D002545:Brain Ischemia / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D019468:Disease Management; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007036:Hypothermia, Induced; D007362:Intensive Care Units / Q000706:statistics & numerical data; D019586:Intracranial Hypertension / Q000209:etiology / Q000628:therapy; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D020521:Stroke / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D013997:Time Factors
D000925:Anticoagulants; D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D018696:Neuroprotective Agents